ARTICLE

FindCenter AddIcon

World-First Clinical Trial Explores Safety and Efficacy of DMT for Major Depression

By Ruairi J. Mackenzie — 2020

The world’s first clinical trial testing the efficacy of the psychedelic compound N,N-dimethyltryptamine (DMT) has won approval from the UK Medicines and Healthcare products Regulatory Agency (MHRA).

Read on www.technologynetworks.com

FindCenter Post-Image
27:57

How Psychedelics Can Treat Depression - Robin Carhart Harris

The talk will review brain imaging work on the action of psychedelics on the brain and describe the results of a clinical trial assessing psilocybin as a treatment for depression. It will also review the broader societal impact of psychedelic drug-use and discuss its implications.

Video
Robin Carhart-Harris
2016
FindCenter AddIcon
FindCenter Post-Image

How to Change Your Mind: What the New Science of Psychedelics Teaches Us about Consciousness, Dying, Addiction, Depression, and Transcendence

When Michael Pollan set out to research how LSD and psilocybin (the active ingredient in magic mushrooms) are being used to provide relief to people suffering from difficult-to-treat conditions such as depression, addiction, and anxiety, he did not intend to write what is undoubtedly his most...

Book
Michael Pollan
2019
FindCenter AddIcon
FindCenter Post-Image
35:24

DMT—The Hidden Truth (2019)

Video
2019
FindCenter AddIcon
FindCenter Post-Image
17:18

Dr. Robin Carhart Harris: Psilocybin and the Psychedelic State

Dr. Robin Carhart-Harris, of the Neuropsychopharmacology Unit, Imperial College London, discusses research on Psilocybin and how psychedelics could be used in therapy to help with depression, addiction, and other problems of rigid thought patterns.

Video
Robin Carhart-Harris
2013
FindCenter AddIcon

EXPLORE TOPIC

DMT